Please assess the completion status of the following clinical trial:

Trial Title: Duloxetine for Postoperative Pain of Laparoscopic Cholecystectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 1. Patients who are scheduled to undergo elective LC~Exclusion Criteria:~1- Patients with acute pancreatitis 2. Patients undergoing chronic pain treatment 3. Patients who received analgesics or sedatives 24 h before scheduled surgery 3. Patients had alcohol or drug addiction 4. Severe hepatic and renal dysfunction 5. Previous allergic response to duloxetine 6. Pregnancy and lactation 7. Patients with communication problems, cognitive dysfunction, or psychological disorders

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Intervention (Type: ACTIVE_COMPARATOR): patients scheduled for elective LC will receive 60 mg duloxetine before surgery
- Control (Type: PLACEBO_COMPARATOR): patients scheduled for elective LC will receive placebo before surgery

Based on this trial design, predict the completion outcome and termination type (if applicable).